Global Registry for Endovascular Aortic Treatment (GREAT)
GREAT
'GREAT' Global Registry for Endovascular Aortic Treatment - Outcomes Evaluation
1 other identifier
observational
4,600
4 countries
6
Brief Summary
Prospective, observational Registry to obtain data on device performance and clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2010
Longer than P75 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 3, 2012
CompletedFirst Posted
Study publicly available on registry
August 7, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
February 9, 2026
February 1, 2026
16.5 years
August 3, 2012
February 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To collect "real world" data on the incidence of serious device events.
Up to 10 years
Study Arms (1)
Endovascular aortic repair
Patients treated with Gore Endovascular Aortic Products.
Interventions
Treatment with Gore Endovascular Aortic Products.
Eligibility Criteria
Consecutive series of patients who undergo treatment with Gore endovascular aortic products.
You may qualify if:
- Minimum age required by state regulations
- Indication for aortic endovascular stent graft repair
- Signed informed consent
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
The University of Chicago Medicine & Biological Sciences
Chicago, Illinois, 60637, United States
Baylor Research Institute
Plano, Texas, United States
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
Coris Medicina Avançada
Florianópolis, Brazil
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
Milan, Italy
IRCCS Policlinico San Donato
Milan, Italy
Related Publications (5)
Grassi V, Trimarchi S, Weaver F, de Beaufort HWL, Azzizzadeh A, Upchurch GR Jr, Piffaretti G, Lomazzi C; GREAT participants. Endovascular repair of descending thoracic aortic aneurysms-a mid-term report from the Global Registry for Endovascular Aortic Treatment (GREAT). Eur J Cardiothorac Surg. 2022 Jan 24;61(2):357-364. doi: 10.1093/ejcts/ezab366.
PMID: 34392333DERIVEDBaxter RD, Hansen SK, Gable CE, DiMaio JM, Shutze WP, Gable DR; GREAT Investigators. Outcomes of Open Versus Percutaneous Access for Patients Enrolled in the GREAT Registry. Ann Vasc Surg. 2021 Jan;70:370-377. doi: 10.1016/j.avsg.2020.06.033. Epub 2020 Jun 27.
PMID: 32603847DERIVEDPiffaretti G, Grassi V, Lomazzi C, Brinkman WT, Navarro TP, Jenkins MP, Trimarchi S; GREAT participants. Thoracic endovascular stent graft repair for ascending aortic diseases. J Vasc Surg. 2019 Nov;70(5):1384-1389.e1. doi: 10.1016/j.jvs.2019.01.075. Epub 2019 May 21.
PMID: 31126763DERIVEDShutze W, Suominen V, Jordan W, Cao P, Oweida S, Milner R. The incidence and effect of noncylindrical neck morphology on outcomes after endovascular aortic aneurysm repair in the Global Registry for Endovascular Aortic Treatment. J Vasc Surg. 2018 Dec;68(6):1714-1724. doi: 10.1016/j.jvs.2018.03.394. Epub 2018 May 24.
PMID: 29803683DERIVEDBriggs C, Babrowski T, Skelly C, Milner R. Anatomic and clinical characterization of the narrow distal aorta and implications after endovascular aneurysm repair. J Vasc Surg. 2018 Oct;68(4):1030-1038.e1. doi: 10.1016/j.jvs.2017.12.073. Epub 2018 May 22.
PMID: 29802041DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ross Milner, MD, FACS
The University of Chicago Medicine & Biological Sciences
- PRINCIPAL INVESTIGATOR
Dennis Gable, MD
Baylor Research Institute
- PRINCIPAL INVESTIGATOR
Pierre Galvagni Silveira, MD, PhD
Coris Medicina Avançada
- PRINCIPAL INVESTIGATOR
Steven R Dubenec, MD
Royal Prince Alfred Hospital, Sydney, Australia
- PRINCIPAL INVESTIGATOR
Santi Trimarchi, MD
IRCCS Policlinico S. Donato
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2012
First Posted
August 7, 2012
Study Start
December 1, 2010
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
February 9, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share